Biomoda Inc. Hires Anthony Nakhla, Ph.D., to Spearhead Manufacturing Efforts.ALBUQUERQUE, N.M. -- Expert in Transferring Product Technology from R&D Through Manufacturing to Aid Biomoda in Commercialization of CyPath. Biomoda Inc. and Anthony Nakhla, Ph.D., have entered into an agreement for Nakhla to provide his research, development and manufacturing expertise to Biomoda for the manufacture of CyPath (Biomoda's first diagnostic product) and future products. Nakhla will collaborate with the Biomoda team with the objective of having CyPath manufactured by FDA- and EU-approved contract manufacturers. The manufacture of CyPath is the next step in the commercialization of Biomoda's first diagnostic product: a noninvasive non·in·va·sive adj. 1. Not penetrating the body, as by incision. Used especially of a diagnostic procedure. 2. Not invading healthy tissue. test for lung cancer lung cancer, cancer that originates in the tissues of the lungs. Lung cancer is the leading cause of cancer death in the United States in both men and women. Like other cancers, lung cancer occurs after repeated insults to the genetic material of the cell. . Nakhla has extensive experience in transferring technology from the research and development stage to the manufacture of clinical material and beyond. His expertise will support Biomoda through this significant next step of commercialization. "We at Biomoda are very pleased to have Tony as a member of the team," said Dr. Herbert Whitaker, executive vice president of Biomoda. "His expertise will expedite ex·pe·dite tr.v. ex·pe·dit·ed, ex·pe·dit·ing, ex·pe·dites 1. To speed up the progress of; accelerate. 2. our commercialization program to have CyPath on the market in early 2006." Prior to his current endeavors, Nakhla was employed by Cardinal Health's contract manufacturing division in Albuquerque, N.M., and Lipex Biomembranes of Vancouver, British Columbia British Columbia, province (2001 pop. 3,907,738), 366,255 sq mi (948,600 sq km), including 6,976 sq mi (18,068 sq km) of water surface, W Canada. Geography , Canada. He earned a Ph.D. in biochemistry biochemistry, science concerned chiefly with the chemistry of biological processes; it attempts to utilize the tools and concepts of chemistry, particularly organic and physical chemistry, for elucidation of the living system. from the Memorial University of Newfoundland Memorial University of Newfoundland, at St. John's, N.L., Canada; provincially supported; coeducational; founded 1925 as Memorial Univ. College. It achieved university status in 1949. , Canada. Biomoda Inc., a development stage in-vitro diagnostics organization, is focused on research, development and commercialization of cancer diagnostics. The company has several patents developed for noninvasive early detection and treatment of specific cancers, and is in the process of registering additional patents in this area. The company's proprietary technologies provide minimally invasive and minimal-impact approaches as cancer-diagnostic products. Biomoda's laboratory operations are situated at Kirtland Air Force Base Kirtland Air Force Base is located in the southeast quadrant of Albuquerque, New Mexico, adjacent to the Albuquerque International Sunport. The base is the third largest installation in Air Force Materiel Command, covering 51,558 acres (209 km²) and employing over 23,000 people, (Albuquerque, N.M.). This news release contains forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. that involve a high degree of risk and uncertainty. Such statements include, but are not limited to, statements containing the words "believes," "anticipates," "expects," "estimates," and words of similar import. The company's actual results could differ materially from any forward-looking statements, which reflect management's opinions only as of the date of this report, as a result of risks and uncertainties that exist in our operation, development efforts and business environment. The company undertakes no obligation to revise or publicly release the results of any revisions to these forward-looking statements. You should carefully review the risk factors in other documents that the company files from time to time with the Securities and Exchange Commission, including its Quarterly Reports on Form 10-Q Form 10-Q See 10-Q. . For additional information, visit the Biomoda Web site at www.biomoda.com or call us at 505-821-0875. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion